Clinical Trials Browser

Leukemia, Myeloid, Acute

Breast Neoplasms

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Bone Marrow Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

Adenomatous Polyposis Coli, Colorectal Neoplasms

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Adenocarcinoma Of Esophagus, Barrett Esophagus

Esophageal Neoplasms, Ornithine Carbamoyltransferase Deficiency Disease

Multiple Myeloma

Leukemia, Myeloid, Acute

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

Thyroid Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Lung Neoplasms

Carcinoma, Small Cell, Small Cell Lung Carcinoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Plasmablastic Lymphoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

Glioblastoma, Gliosarcoma

Neuroblastoma, Ganglioneuroblastoma

Ann Arbor Stage II Mantle Cell Lymphoma

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Multiple Myeloma

Anus Neoplasms, Chlamydia Infections, Gonorrhea

Motor Activity, Pancreatic Neoplasms

Cancer of Biliary Duct

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Epstein-Barr Virus Infections

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung, Postoperative Complications

Neuroma, Acoustic, Postoperative Nausea and Vomiting

Carcinoma, Hepatocellular

Multiple Myeloma

Emergence Delirium, Carcinoma, Renal Cell, Prostatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Neoplasms

Advanced/Metastatic Solid Tumors

Advanced Malignant Solid Tumors

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

Peripheral Nervous System Diseases

Stomach Neoplasms

Tubo-ovarian Carcinoma

Hodgkin Disease

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Endometrial Hyperplasia

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

CBD for Breast Cancer Primary Tumors

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Outside the Cage (OTC) Robotic Esophagectomy

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

RICEPS-2

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

PEACHES 2

HY-PANC

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

VENP-A-QUI

PREHAB

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery

ADVANCED-3

Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor

A Phase II Clinical Study Evaluating the Safety, Tolerability,Pharmacokinetics, and Preliminary Efficacy of JS212 andJS213 as Monotherapy and in Combination in Patients Withadvanced Malignant Solid Tumors

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

EX-CIPN

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

FIMBRIMENOP

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

ALANIS

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.